Harmony Biosciences Holdings Inc
Harmony Biosciences Holdings Inc (HRMY) Covered Calls
Harmony Biosciences Holdings Inc trades in the Biotechnology industry with an IV Rank of 36.51%, average versus the past year. HRMY's highest covered call setup is the $42.50 strike expiring Feb 19, 2027, sorted by theoretical annualized return. It's 30.41% out of the money with 91 days to expiration, a 31.33% return until expiration, and a 125.66% theoretical annualized return. Across the setups shown, annualized returns run from 65.93% to 125.66% at strikes between $37.50 and $47.50, with 56 to 238 days to expiration, as of Nov 20, 2026.
Read more
Running HRMY covered calls helps you generate income from Harmony Biosciences Holdings Inc shares you already own, turning a long stock position into a yield producing asset. A covered call means holding the underlying stock and selling a call option against it, collecting premium in exchange for capping upside at the strike. Use our scanner to find the best HRMY covered calls in real time and filter for the strikes, expiries, and premiums that fit your strategy.
A covered call pairs limited risk with a clear income profile. If HRMY stays below the strike at expiration, you keep the premium and the shares. If it rises above, you deliver the stock at the strike and still pocket the premium. Selling HRMY covered calls works best when implied volatility is elevated, since richer premiums improve the risk reward. Key inputs include strike selection relative to delta, days to expiration, annualized return, and probability of assignment, all of which determine whether a given HRMY covered call is worth writing.
Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, develops and commercializes therapies for patients with rare neurological disorders in the United States. Its product, WAKIX is a medication for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. The company was formerly known as Harmony Biosciences II, Inc. and changed its name to Harmony Biosciences Holdings, Inc. in February 2020. Harmony Biosciences Holdings, Inc. was incorporated in 2017 and is based in Plymouth Meeting, Pennsylvania.
| 2027-02-19 | 91 | 42.50 | 30.41 | 0.30 | 4.40 | 1021.00 | 31.33 | 125.66 | -0.92 | +0.33 | 0 | 4.10 |
| 2027-04-16 | 147 | 47.50 | 45.75 | 0.85 | 3.10 | 1576.00 | 48.36 | 120.07 | -2.61 | +0.28 | 0 | 2.25 |
| 2027-01-15 | 56 | 37.50 | 15.07 | 0.30 | 4.30 | 521.00 | 15.99 | 104.20 | -0.92 | +0.39 | 7 | 4.00 |
| 2027-04-16 | 147 | 45.00 | 38.08 | 1.05 | 3.60 | 1346.00 | 41.30 | 102.55 | -3.22 | +0.31 | 3 | 2.55 |
| 2027-02-19 | 91 | 40.00 | 22.74 | 0.60 | 4.70 | 801.00 | 24.58 | 98.58 | -1.84 | +0.38 | 2 | 4.10 |
| 2027-04-16 | 147 | 42.50 | 30.41 | 0.80 | 4.70 | 1071.00 | 32.86 | 81.60 | -2.45 | +0.36 | 5 | 3.90 |
| 2027-02-19 | 91 | 37.50 | 15.07 | 1.50 | 5.40 | 641.00 | 19.67 | 78.89 | -4.60 | +0.45 | 9 | 3.90 |
| 2027-07-16 | 238 | 47.50 | 45.75 | 0.95 | 4.90 | 1586.00 | 48.67 | 74.63 | -2.92 | +0.34 | 0 | 3.95 |
| 2027-04-16 | 147 | 40.00 | 22.74 | 1.50 | 5.30 | 891.00 | 27.34 | 67.88 | -4.60 | +0.42 | 275 | 3.80 |
| 2027-07-16 | 238 | 45.00 | 38.08 | 1.60 | 5.50 | 1401.00 | 42.99 | 65.93 | -4.91 | +0.38 | 0 | 3.90 |
As of Nov 20, 2026
Prices move. This one stays.Lock in 5 years at a special price and save $1,503. Ending soon.See the Black Friday deal →Stock Statistics
- IndustryBiotechnology
- SectorHealthcare
- IV Rank36.51% Moderate
- Market cap (M$)1,914
- 52 weeks high-25.06%
- 52 weeks low25.83%
- Analyst recommendationBuy
1.75 - Target price$48.08
47.53% above the current stock price - Dividend—
- Payout ratio0.00%
- Earnings date2026-11-04
- P/E10.77
- Future P/E8.26
- EPS (ttm)3.03
- EPS growth next 5 years18.41%
As of Nov 20, 2026